Align Technology | Actif À Court Terme



Current Assets Changement Date
3M USD 15.88B 415M 2024-12
Align Technology USD 2.49B 104.95M 2024-12
Becton, Dickinson and Co. USD 8.66B 1.81B 2024-12
Bruker USD 2.06B 133.1M 2024-12
Cardinal Health USD 35.76B 2.85B 2024-12
Charles River Laboratories USD 1.4B 91.65M 2024-12
Cooper Companies USD 1.99B 35.5M 2025-01
CVS Health USD 68.65B 1.3B 2024-12
Danaher USD 9.5B 563M 2024-12
Dentsply International USD 1.75B 175M 2024-12
Dexcom USD 4.3B 38.6M 2024-12
Henry Schein USD 3.98B 164M 2024-12
Idexx Laboratories USD 1.4B 33.85M 2024-12
Insulet USD 1.89B 30.4M 2024-12
Integra LifeSciences USD 1.08B 17.84M 2024-12
IQVIA Holdings USD 5.83B 197M 2024-12
Masimo USD 1.23B 54.1M 2024-12
McKesson USD 51.74B 1.6B 2024-12
Mettler Toledo International USD 1.19B 4.33M 2024-12
Patterson Companies USD 1.84B 4.38M 2025-01
Revvity USD 2.35B 98.8M 2024-12
Solventum Corp 3.25B 105M 2024-12
Stryker USD 14.85B 174M 2024-12
Teleflex USD 1.47B 28.18M 2024-12
Thermo Fisher Scientific USD 22.14B 1.65B 2024-12
Veeva Systems USD 6.31B 861.64M 2025-01
Walgreens Boots Alliance USD 16.24B 1.24B 2025-02
Waters USD 1.67B 21.39M 2024-12
Zimmer Biomet Holdings USD 4.67B 192.5M 2024-12
Zoetis USD 5.99B 296M 2024-12



Align Technology Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.